Viewing Study NCT02487095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-01-29 @ 11:59 PM
Study NCT ID: NCT02487095
Status: COMPLETED
Last Update Posted: 2025-04-13
First Post: 2015-06-27
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small -Cell Lung View
None Ovarian Neoplasms View
None Small Cell Lung Carcinoma View
None Uterine Cervical Neoplasms View
None Carcinoma, Neuroendocrine View
None Extrapulmonary Small Cell Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RB1 Inactivation View
None Kinase Inhibitor View
None DNA Damage Response Network View
None MYC And CCNE1 Activation View
None Defective ATM-p53 Signaling Pathway View